Invesco India Contra Fund
Institution · data to Jun 2026
Disclosed value
₹2,639 Cr
Jun 2026 closes
At current prices
…
Current holdings
6
Tracked since
Sep 2021
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Glenmark Pharmaceuticals Ltd | 2.20% | NEW | ₹1,375 Cr |
| Shyam Metalics & Energy Ltd | 1.41% | 0.24 | ₹375 Cr |
| Sonata Software Ltd | 4.77% | flat | ₹371 Cr |
| Cohance Lifesciences Ltd | 1.69% | 0.25 | ₹294 Cr |
| Blackbuck Ltd | 1.25% | 0.01 | ₹125 Cr |
| V-Mart Retail Ltd | 1.55% | flat | ₹98 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, Invesco India Contra Fund — an institution tracked through public shareholding filings — disclosed 6 holdings in Indian listed companies worth ₹2,639 crore. The same holdings-at-filing-value basis put it at ₹677 crore in Mar 2026 (+289.7%). Solomo carries these filings back to Sep 2021.
Largest disclosed positions in Jun 2026: Glenmark Pharmaceuticals Ltd (GLENMARK — 2.20% of the company, ₹1,375 crore); Shyam Metalics & Energy Ltd (SHYAMMETL — 1.41% of the company, ₹375 crore); Sonata Software Ltd (SONATSOFTW — 4.77% of the company, ₹371 crore); Cohance Lifesciences Ltd (COHANCE — 1.69% of the company, ₹294 crore); Blackbuck Ltd (BLACKBUCK — 1.25% of the company, ₹125 crore). Those 5 account for 96% of the disclosed value.
Changes in the Jun 2026 filings: newly disclosed — Glenmark Pharmaceuticals Ltd. Stake raised in Cohance Lifesciences Ltd (+0.25 pp). Stake reduced in Blackbuck Ltd (−0.01 pp).
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹2,639 Cr | +289.7% |
| Mar 2026 | ₹677 Cr | −77.5% |
| Dec 2025 | ₹3,013 Cr | +130% |
| Sep 2025 | ₹1,310 Cr | −52.6% |
| Jun 2025 | ₹2,766 Cr | +171.7% |
| Mar 2025 | ₹1,018 Cr | +49% |
| Dec 2024 | ₹683 Cr | −29.5% |
| Sep 2024 | ₹969 Cr | +33.7% |